Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Evaluation of Eli Lilly's triple agonist, Retatrutide for Treating Obesity

Ticker(s): LLY

Who's the expert?

Institution: University of Arkansas Medical Services Health

Director of the diabetes program at UAMS Health
Manages about 600 patients with type 2 diabetes and 200 patients on insulin pumps
Clinical and research interests include type 1 diabetes, type 2 diabetes, Diabetes management with exercise, insulin pumps, closed-look insulin pump systems, and continuous glucose monitoring systems

Interview Goal

This call will focus on the landscape of obesity and the potential of Eli Lilly's triple agonist, Retatrutide.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here To Join
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Call Date: Mar 29, 2026
Call Time: 01:30 PM EDT

Wall Street Time

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here To Join
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.